FLT1 抗体
(Fms-Related tyrosine Kinase 1 (VEGFR1) (FLT1))
This gene encodes a member of the vascular endothelial growth factor receptor (VEGFR) family. VEGFR family members are receptor tyrosine kinases (RTKs) which contain an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and a tyrosine kinase (TK) domain within the cytoplasmic domain. This protein binds to VEGFR-A, VEGFR-B and placental growth factor and plays an important role in angiogenesis and vasculogenesis. Expression of this receptor is found in vascular endothelial cells, placental trophoblast cells and peripheral blood monocytes. Multiple transcript variants encoding different isoforms have been found for this gene. Isoforms include a full-length transmembrane receptor isoform and shortened, soluble isoforms. The soluble isoforms are associated with the onset of pre-eclampsia.[provided by RefSeq, May 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| FLT1 抗体 (C-Term) | 人, 大鼠, 犬, 豚鼠, 马, Cow, 兔, 山羊 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (C-Term) (Biotin) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (C-Term) (HRP) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (N-Term) (Biotin) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (N-Term) (HRP) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (AA 27-399) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (AA 27-399) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (AA 27-73) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (AA 27-73) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (N-Term) (HRP) | 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (N-Term) (Biotin) | 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (AA 27-399) | 人 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (C-Term) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (N-Term) | 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (C-Term) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (N-Term) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (C-Term) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (AA 27-73) | 人 | 兔 Polyclonal |
|
|
|
| FLT1 抗体 (AA 32-1229) | 斑马鱼 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 大鼠, 犬, 豚鼠, 马, Cow, 兔, 山羊
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 27-399
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 27-399
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 27-73
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 27-73
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 27-399
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 27-73
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 斑马鱼
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 32-1229
Latest Publications for our FLT1 抗体
: "Tumor Microenvironment Modulates Immunological Outcomes of Myeloid Cells with mTORC1 Disruption." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 202, Issue 5, pp. 1623-1634, (2019) (PubMed).
: "MMP14-Containing Exosomes Cleave VEGFR1 and Promote VEGFA-Induced Migration and Proliferation of Vascular Endothelial Cells." in: Investigative ophthalmology & visual science, Vol. 60, Issue 6, pp. 2321-2329, (2019) (PubMed).
: "Ferrochelatase is a therapeutic target for ocular neovascularization." in: EMBO molecular medicine, Vol. 9, Issue 6, pp. 786-801, (2018) (PubMed).
: "Sesquiterpene binding Gly-Leu-Ser/Lys-"co-adaptation pocket" to inhibit lung cancer cell epithelial-mesenchymal transition." in: Oncotarget, Vol. 8, Issue 41, pp. 70192-70203, (2018) (PubMed).
: "Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma." in: Oncogene, (2018) (PubMed).
: "A quantitative method for screening and identifying molecular targets for nanomedicine." in: Journal of controlled release : official journal of the Controlled Release Society, Vol. 263, pp. 57-67, (2018) (PubMed).
: "Placental soluble fms-like tyrosine kinase expression in small for gestational age infants and risk for adverse outcomes." in: Placenta, Vol. 52, pp. 10-16, (2018) (PubMed).
: "VEGF vascularization pathway in human intervertebral disc does not change during the disc degeneration process." in: BMC research notes, Vol. 11, Issue 1, pp. 333, (2018) (PubMed).
: "A novel polysaccharide from Sargassum integerrimum induces apoptosis in A549 cells and prevents angiogensis in vitro and in vivo." in: Scientific reports, Vol. 6, pp. 26722, (2018) (PubMed).
: "Intravitreal Injection of AAV Expressing Soluble VEGF Receptor-1 Variant Induces Anti-VEGF Activity and Suppresses Choroidal Neovascularization." in: Investigative ophthalmology & visual science, Vol. 59, Issue 13, pp. 5398-5407, (2018) (PubMed).
: "MMP14-Containing Exosomes Cleave VEGFR1 and Promote VEGFA-Induced Migration and Proliferation of Vascular Endothelial Cells." in: Investigative ophthalmology & visual science, Vol. 60, Issue 6, pp. 2321-2329, (2019) (PubMed).
: "Ferrochelatase is a therapeutic target for ocular neovascularization." in: EMBO molecular medicine, Vol. 9, Issue 6, pp. 786-801, (2018) (PubMed).
: "Sesquiterpene binding Gly-Leu-Ser/Lys-"co-adaptation pocket" to inhibit lung cancer cell epithelial-mesenchymal transition." in: Oncotarget, Vol. 8, Issue 41, pp. 70192-70203, (2018) (PubMed).
: "Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma." in: Oncogene, (2018) (PubMed).
: "A quantitative method for screening and identifying molecular targets for nanomedicine." in: Journal of controlled release : official journal of the Controlled Release Society, Vol. 263, pp. 57-67, (2018) (PubMed).
: "Placental soluble fms-like tyrosine kinase expression in small for gestational age infants and risk for adverse outcomes." in: Placenta, Vol. 52, pp. 10-16, (2018) (PubMed).
: "VEGF vascularization pathway in human intervertebral disc does not change during the disc degeneration process." in: BMC research notes, Vol. 11, Issue 1, pp. 333, (2018) (PubMed).
: "A novel polysaccharide from Sargassum integerrimum induces apoptosis in A549 cells and prevents angiogensis in vitro and in vivo." in: Scientific reports, Vol. 6, pp. 26722, (2018) (PubMed).
: "Intravitreal Injection of AAV Expressing Soluble VEGF Receptor-1 Variant Induces Anti-VEGF Activity and Suppresses Choroidal Neovascularization." in: Investigative ophthalmology & visual science, Vol. 59, Issue 13, pp. 5398-5407, (2018) (PubMed).
Aliases for FLT1 抗体
fms related tyrosine kinase 1 (FLT1) 抗体FMS-related tyrosine kinase 1 (Flt1) 抗体
vascular endothelial growth factor receptor 1 (CpipJ_CPIJ012087) 抗体
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (flt1) 抗体
FMS-like tyrosine kinase 1 (Flt1) 抗体
fms related tyrosine kinase 1 (Flt1) 抗体
vascular endothelial growth factor receptor-1 (FLT-1) 抗体
AI323757 抗体
FLT 抗体
FLT-1 抗体
Flt-1 抗体
FLT1 抗体
flt1b 抗体
sFlt1 抗体
VEGFR-1 抗体
VEGFR1 抗体
您还需要查找其他产品吗？
You are here:
